23 July 2021 - Deborah Wilkes
Premium
Johnson & Johnson (J&J) expects to see “more normalised growth” in the second half of 2021 as “consumers return to typical usage patterns”.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.